Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00753285 · ClinicalTrials.gov registry record · NA
Renal Denervation in Patients With Refractory Hypertension
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00753285: Completed NA study, sponsored by Medtronic Vascular.
NCT00753285 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00753285, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.
Interventions
- DEVICE Renal Denervation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-05 |
| Phase | NA |
What the finished NCT00753285 record still lists
NCT00753285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Renal Denervation is the first listed.
NCT00753285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00753285 about?
NCT00753285 is a clinical study titled "Renal Denervation in Patients With Refractory Hypertension". The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.
What is the current status of trial NCT00753285?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2008-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00753285?
The interventions under investigation include: Renal Denervation (DEVICE).
Who is sponsoring clinical trial NCT00753285?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00753285's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia